|
Nov 27
|
Haemonetics (HAE) Stock Up 4.2% YTD: Will the Rally Continue?
|
|
Nov 27
|
Haemonetics' (HAE) Plasma Growth, Innovation Aid Performance
|
|
Nov 27
|
Here's Why Investors Should Retain Labcorp (LH) Stock for Now
|
|
Nov 24
|
Orthofix (OFIX) Q3 Earnings Top Estimates, 2023 Sales View Cut
|
|
Nov 24
|
Labcorp (LH) Closes the Legacy Health Asset Acquisition Deal
|
|
Nov 23
|
EssilorLuxottica (ESLOY), Moncler Ink Luxury Eyewear Deal
|
|
Nov 23
|
Here's Why You Should Retain Edward Lifesciences (EW) Stock Now
|
|
Nov 10
|
Is Haemonetics (HAE) a Solid Growth Stock? 3 Reasons to Think "Yes"
|
|
Nov 9
|
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
|
|
Nov 8
|
Chemed's (CHE) VITAS Performance Aids, Macro Issues Linger
|
|
Nov 7
|
Insulet (PODD) Banks on Omnipod for Consistent Market Share Gain
|
|
Nov 7
|
QIAGEN (QGEN) Launches Workflow to Boost Microbiome Research
|
|
Nov 6
|
Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term
|
|
Nov 6
|
QIAGEN's (QGEN) Molecular Diagnostics Gains Share, FX Woe Stays
|
|
Nov 5
|
Haemonetics Corporation (NYSE:HAE) Q2 2024 Earnings Call Transcript
|
|
Nov 3
|
Haemonetics (HAE) Q2 Earnings Top Estimates, 2024 View Up
|
|
Nov 2
|
Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics
|
|
Nov 2
|
Haemonetics Corp (HAE) Reports 7% Revenue Increase in Q2 Fiscal 2024
|
|
Nov 2
|
OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS
|
|
Nov 2
|
Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
|